CPG for Eating Disorders

– Synthesis and analysis of the scientific evidence. Different templates were used forinformation retrieval. Information regarding the main characteristics of the studies wasobtained and then synthesised in evidence tables for a subsequent qualitative analysis. Whenthe SRSE or CPGs reported the results of individual studies, these results were described in thesection “scientific evidence”.In Annex 6.2 results of the CPG’s search, selection and assessment of quality are described. InAnnex 6.3. and Annex 6.4. NICE’s CPG 30 and AHRQ’s SRSE 31 are respectively described,representing the main scientific base on which this guide is founded.– Formulation of recommendations based on formal assessment or on SIGN’s consideredjudgement. The grading of recommendations has been performed using SIGN’s system (SeeAnnex 1). Recommendations pertaining to the NICE CPG have been considered by theworking group and have been classified as: adopted (and, hence, accepted; they have simplybeen translated into Spanish) or adapted (and, hence, modified: changes have been made withthe purpose of contextualising them to our setting). Controversial recommendations or thoselacking in evidence have been resolved by the working group’s consensus. The category ofeach recommendation appears in the chapters.– Description of psychological therapies. Definitions are derived from the NICE 30 guide, fromthe SRSE where they have been assessed and from the working group itself (See Annex 4).– Description of drugs (mechanism of action and approved indications in Spain) included in theCPG. The following websites have been consulted: Spanish Drug Agency (AGEMED)(https://agemed.es) and Vademecum (http://www.vademecum.es). It is recommended to readthe technical chart of each drug before any therapeutic prescription given that the CPG onlyincludes a very brief description of each drug and does not go into depth in terms of schemes,contraindications, etc. (See Annex 4).– Legal aspects. To develop this chapter, aside from reviewing the current legislation in ourcountry, several different articles and reference documents 17, 46-49 have been consulted.– To develop patient information (See Annex 3.1.), a search has been performed for pamphletsand other documents containing information for the patient/carer both in printed and electronicformats. To this end, all documents identified in the websites of three relevant organizations(www.feacab.org, www.itacat.com and www.adaner.org) that comprise the majority ofassociations declared of public use at a national level through their different delegations andsupport groups and the material provided by the clinical coordinator have been reviewed.Following the review of these documents, a content comparison table was elaborated from whichthe table of contents was developed. Once consensus of the final version had been reached bythe working group and collaborating experts, the Association in Defence of Anorexia Nervosaand Bulimia Management (ADANER) and the Spanish Federation of Support Associations forAnorexia (FEACAB), which include most local organisations, carried out an external review,using a specifically designed questionnaire that inquired on the suitability of the informationprovided, the examples used, style and language, etc. Although this information is part of theCPG and must be delivered and explained to the patient/carer by health care professionals, wehope to edit individualised pamphlets that facilitate its dissemination.45CLINICAL PRACTICE GUIDELINE FOR EATING DISORDERS